Quality of Life in Patients With Liver Cancer Treated With Image-Guided Therapy

Outcomes Following Image-Guided Therapy for Hepatic Malignancies

RATIONALE: Gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy may help the study of cancer in the future.

PURPOSE: This clinical trial is gathering information about quality of life over time from patients with liver cancer treated with image-guided therapy.

OBJECTIVES:

• Develop a data repository for clinical and health-related quality of life outcome measures in patients with hepatic malignancies treated with image-guided therapies.

OUTLINE: This is a pilot, prospective, longitudinal study.

Patients complete a standard questionnaire assessing health-related quality of life at baseline, during routine follow-up care after image-guided therapy, and then annually thereafter. Health and disease status and the development of other illnesses are assessed by medical record review.

PROJECTED ACCRUAL: Not specified

DISEASE CHARACTERISTICS:

• Undergoing concurrent image-guided therapy for hepatic malignancies using any of the following imaging techniques:

  • X-ray
  • Ultrasound
  • MRI
  • CT scan
  • Nuclear medicine imaging

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• See Disease Characteristics